Advertisement
Screener

KAIROS PHARMA, LTD. (KAPA) Cash and Restricted Cash

1.7 / 5 stars · 4/12 Roast Me

KAIROS PHARMA, LTD. Cash and Restricted Cash

KAIROS PHARMA, LTD. (KAPA) had Cash and Restricted Cash of $2.63 million as of 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12

  • 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.63M.
  • 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.67M.
  • 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.49M.
  • 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.58M.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
2026-06-30$2.63M
10-Q · filed 2026-08-12
2026-03-31$3.67M
10-Q · filed 2026-05-13
2025-12-31$4.49M
10-Q · filed 2026-08-12
2025-09-30$5.58M
10-Q · filed 2025-11-14
2025-06-30$3.03M
10-Q · filed 2026-08-12
2025-03-31$3.62M
10-Q · filed 2026-05-13
2024-12-31$1.27M
10-Q · filed 2026-08-12
2024-09-30$3.22M
10-Q · filed 2025-11-14
2024-06-30$21.00K
10-Q · filed 2025-08-12
2024-03-31$40.00K
10-Q · filed 2025-05-14
2023-12-31$93.00K
10-K · filed 2026-03-31
2023-09-30$99.00K
10-Q · filed 2024-11-14
2022-12-31$437.00K
10-K · filed 2025-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
VERU INC. (VERU)United States$0.043B-3.93
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
CervoMed Inc. (CRVO)United States$0.038B-1.39
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Celularity Inc (CELU)United States$0.038B-0.34
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05